• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
1,962 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4746

Formosa Laboratories
NT$96.20-4.8%6.1%NT$11.6bNT$137.50PE91.6xS13.9%2.1%

A086060

GeneBioTech Ltd
₩3,940.001.5%-7.9%₩33.9bn/aPE13.1xn/a0%

A220100

FutureChemLtd
₩12,590.00-4.5%60.6%₩278.2bn/aPS19.9xn/an/a

A127120

DNA Link
₩2,900.0017.4%-12.1%₩54.2bn/aPS2.5xn/an/a

PER

Percheron Therapeutics
AU$0.089.6%14.3%AU$72.1mn/aPS31.5xE-27.3%n/a

A043090

TechnologyLtd
₩431.00-1.4%-72.7%₩30.6bn/aPS1.9xn/an/a

688276

Changchun BCHT Biotechnology
CN¥40.453.5%-40.1%CN¥16.7bCN¥54.57PE30.8xE26.2%0.4%

GTG

Genetic Technologies
AU$0.138.3%-56.7%AU$17.2mn/aPS1.7xn/an/a

300485

Beijing Science Sun Pharmaceutical
CN¥8.318.6%-21.2%CN¥4.0bn/aPS8.8xn/a0.3%

2566

Jilin Jian Yisheng Pharmaceutical
CN¥7.343.8%-12.4%CN¥2.4bn/aPE27.9xn/a2.0%

300519

Zhejiang Xinguang Pharmaceutical
CN¥13.163.4%-17.8%CN¥2.1bn/aPE37.1xn/a3.8%

4886

ASKA Pharmaceutical HoldingsLtd
JP¥2,117.00-7.7%61.9%JP¥60.0bJP¥2,666.67PE9.2xE-0.5%1.9%

8225

China Health Group
HK$0.139.2%-33.0%HK$129.4mn/aPS5.6xn/an/a

6945

AP Biosciences
NT$61.801.6%n/aNT$4.0bn/aPS124.1xn/an/a

AHEALTH

Apex Healthcare Berhad
RM3.392.7%30.7%RM2.4bRM2.64PE6.1xE-50.3%7.4%

300289

Beijing Leadman BiochemistryLtd
CN¥4.894.7%-13.1%CN¥2.7bn/aPE613.5xn/a0.2%

6676

Sunny Pharmtech
NT$28.500%-17.2%NT$4.2bn/aPS9.9xn/an/a

600750

Jiang Zhong PharmaceuticalLtd
CN¥26.800.5%7.8%CN¥16.7bCN¥31.12PE22.8xE12.9%4.9%

DMC

Domesco Medical Import - Export
₫65,000.00-2.4%41.9%₫2.3tn/aPE13.8xn/a3.8%

RAC

Race Oncology
AU$1.262.0%-31.9%AU$209.4mAU$2.63PS36xE-14.1%n/a

A014570

Korean Drug
₩6,200.000.2%-4.3%₩67.7bn/aPB0.9xn/a2.4%

500124

Dr. Reddy's Laboratories
₹6,056.60-2.4%24.4%₹1.0t₹6,036.20PE18.1xE-1.6%0.7%

7774

Japan Tissue Engineering
JP¥619.00-1.1%7.1%JP¥25.1bJP¥1,200.00PE175.8xn/an/a

524752

Decipher Labs
₹16.111.3%-16.0%₹162.7mn/aPB0.8xn/an/a
Page 29 of 82
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.